Inhibiting ribosomal RNA synthesis in C. elegans protects against reductive stress during de novo fatty acid synthesis deficiency
GENETICS · 04.11.2026 · 234 (3)
DOI: 10.1093/genetics/iyag214 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, online erschienen am 11.08.2026. Verfasst von Jen F Rotti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, United States. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Fatty Acids, RNA, Ribosomal, Stress, Physiological. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Reductive stress has remained underappreciated as a significant disrupter of redox homeostasis. Recent studies have begun to link the accumulation of NADH and NADPH to the development and progression of metabolic diseases such as cancer, cardiac disease, and diabetes. In this study, we use the nematode Caenorhabditis elegans to examine the phenomenon of catastrophic reductive death caused by combined biguanide treatment and fasn-1 deficiency. This process of synergistic biguanide-induced reductive stress correlates with the activation of hypodermal stress response genes and aberrant alternations in the nucleolar morphology of hypodermal cells. Interestingly, we find that loss-of-function and RNAi-based knockdown of the catalytic RNA exosome subunit crn-3 significantly protects against reductive death. RNAi knockdown of multiple other genes involved in rRNA synthesis recapitulate this phenotype. We postulate that this reversal of reductive death can be attributed to impaired ribosomal RNA biogenesis that promotes tolerance of accumulated reducing equivalents Nicotinamide Adenine Dinucleotide Phosphate (NADPH) and Nicotinamide Adenine Dinucleotide (NADH) while also preventing the accumulation of Glutathione (GSH) by potentially activating downstream signaling pathways. Notably, we identify a downstream nuclear RNAi pathway that is activated by phenformin in a fasn-1-dependent manner and is also activated upon disruption of rRNA processing. Overall, we identify a novel mechanism by which pathologic states of reductive stress-related diseases could be ameliorated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, United States.
- Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Harvard University, Boston, MA 02115, United States.
- Broad Institute of Harvard and MIT, Cambridge, MA 02142, United States.
ORCID-Profile: Jen F Rotti, Fasih Ahsan, Armen Yerevanian
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- NIH HHS
- NIH
- NIH Office of Research Infrastructure Programs
- NIH/NIDDK-funded Boston-Area DERC
- Nutrition Obesity Research Center at Harvard
- National Institute on Aging
Zitieren
APA
Rotti, J. F., Ahsan, F., Stuhr, N. L., Emans, S., Soukas, A., & Yerevanian, A. (2026). Inhibiting ribosomal RNA synthesis in C. elegans protects against reductive stress during de novo fatty acid synthesis deficiency. GENETICS, 234(3). https://doi.org/10.1093/genetics/iyag214
Vancouver
Rotti JF, Ahsan F, Stuhr NL, Emans S, Soukas A, Yerevanian A. Inhibiting ribosomal RNA synthesis in C. elegans protects against reductive stress during de novo fatty acid synthesis deficiency. GENETICS. 2026;234(3). doi:10.1093/genetics/iyag214
BibTeX
@article{Rotti2026,
author = {Rotti, Jen F and Ahsan, Fasih and Stuhr, Nicole L and Emans, Sinclair and Soukas, Alexander and Yerevanian, Armen},
title = {Inhibiting ribosomal RNA synthesis in C. elegans protects against reductive stress during de novo fatty acid synthesis deficiency},
journal = {GENETICS},
year = {2026},
volume = {234},
number = {3},
doi = {10.1093/genetics/iyag214}
}
EUVIMED